PART I Note: A glossary of terms used in this Form 10-K appears at the end of this Item 1. Overview We are a diagnostics company with proprietary molecular and bioinformatics technology that we are applying to change disease management worldwide. Our cell-free DNA, or cfDNA, technology combines our novel molecular assays, which reliably measure many informative regions across the genome from samples as small as a single cell, with our statistical algorithms that incorporate data available from t...
Q2 FY2026 — expected 2026-08-11
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-27 | 2025-12-31 | 0001104659-26-020881 | EDGAR | 89K words |
| 2025-02-28 | 2024-12-31 | 0001558370-25-001869 | EDGAR | — |
| 2024-02-29 | 2023-12-31 | 0001558370-24-002083 | EDGAR | — |
| 2023-03-01 | 2022-12-31 | 0001558370-23-002460 | EDGAR | — |
| 2022-02-25 | 2021-12-31 | 0001558370-22-002022 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-07 | 2026-06-30 | 0001628280-26-054525 | EDGAR | — |
| 2026-05-08 | 2026-03-31 | 0001628280-26-032478 | EDGAR | — |
| 2025-11-07 | 2025-09-30 | 0001104659-25-107976 | EDGAR | 31K words |
| 2025-08-08 | 2025-06-30 | 0001558370-25-010829 | EDGAR | — |
| 2025-05-09 | 2025-03-31 | 0001558370-25-007036 | EDGAR | — |
| 2024-11-12 | 2024-09-30 | 0001558370-24-015325 | EDGAR | — |
| 2024-08-09 | 2024-06-30 | 0001558370-24-011666 | EDGAR | — |
| 2024-05-10 | 2024-03-31 | 0001558370-24-007686 | EDGAR | — |
| 2023-11-09 | 2023-09-30 | 0001558370-23-018379 | EDGAR | — |
| 2023-08-04 | 2023-06-30 | 0001558370-23-013289 | EDGAR | — |
| 2023-05-10 | 2023-03-31 | 0001558370-23-008938 | EDGAR | — |
| 2022-11-09 | 2022-09-30 | 0001558370-22-016984 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-06 | 0001604821-26-000015 | EDGAR | — |
| 2026-07-06 | 0001604821-26-000005 | EDGAR | — |
| 2026-06-16 | 0001604821-26-000003 | EDGAR | — |
| 2026-06-05 | 0001604821-26-000002 | EDGAR | — |
| 2026-05-07 | 0001628280-26-032101 | EDGAR | — |
| 2026-04-01 | 0001104659-26-038519 | EDGAR | 1K words |
| 2026-02-26 | 0001104659-26-020482 | EDGAR | — |
| 2026-01-12 | 0001104659-26-002861 | EDGAR | — |
| 2025-12-05 | 0001104659-25-118664 | EDGAR | — |
| 2025-11-06 | 0001104659-25-107727 | EDGAR | — |
77 total filings indexed. 50 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001604821 |
| Ticker | NTRA |
| Exchange | Nasdaq |
| SIC | 8071: Services-Medical Laboratories |
| Incorporated | DE |
| Website | https://www.natera.com |
| Listed | 2015-07-02 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/NTRA (~200 tokens, structured JSON with cryptographic provenance)